Integrated BioPharma, Inc. (NASDAQ:INBP) | WebDisclosure

Basculer en Français

8295	Companies
114809	Keywords
55260	Articles
62422	Press releases

Headlines Articles Press releases Integrated BioPharma, Inc.

Home
Companies
Integrated BioPharma, Inc.

BRIEF

published on 11/13/2024 at 23:38, 7 days 9 hours ago

Integrated BioPharma, Inc. Announces Q3 2024 Financial Results

Revenue Growth Net Income Integrated BioPharma Customer Diversification Q3 2024 Results
BRIEF

published on 11/13/2024 at 23:38, 7 days 9 hours ago

Integrated BioPharma, Inc. annonce ses résultats financiers du troisième trimestre 2024

Croissance Des Revenus Revenu Net Résultats Du 3ème Trimestre 2024 Biopharmacie Intégrée Diversification De La Clientèle
PRESS RELEASE

published on 11/13/2024 at 23:33, 7 days 10 hours ago

Integrated BioPharma Reports Results for its Quarter Ended September 30, 2024
Integrated BioPharma, Inc. reports revenue growth in Q3 2024 with net income of $0.3 million. Diversification of customer base leads to increased financial performance

Revenue Growth Financial Performance Diversification Q3 2024 Integrated BioPharma
BRIEF

published on 09/20/2024 at 23:45, 2 months ago

Integrated BioPharma Announces Financial Results for Quarter and Fiscal Year Ended June 30, 2024

Financial Results Revenue Net Income Operating Income Integrated BioPharma
BRIEF

published on 09/20/2024 at 23:45, 2 months ago

Integrated BioPharma annonce ses résultats financiers pour le trimestre et l'exercice clos le 30 juin 2024

Résultats Financiers Résultat D'exploitation Revenu Net Revenu Biopharmacie Intégrée
PRESS RELEASE

published on 09/20/2024 at 23:40, 2 months ago

Integrated BioPharma Reports Results for Its Quarter and Fiscal Year Ended June 30, 2024
Integrated BioPharma, Inc. reports financial results with minor revenue decrease. Emphasis on core businesses for growth and diversification of customer base

Financial Results Revenue Decrease Customer Base Integrated BioPharma Core Businesses
BRIEF

published on 05/10/2024 at 22:35, 6 months 10 days ago

Integrated BioPharma Releases Financial Results for Q1 2024

Financial Results Quarterly Report Operating Income Revenue Stability Integrated BioPharma
BRIEF

published on 05/10/2024 at 22:35, 6 months 10 days ago

Integrated BioPharma publie ses résultats financiers pour le premier trimestre 2024

Résultats Financiers Rapport Trimestriel Résultat D'exploitation Stabilité Des Revenus BioPharma Intégrée
PRESS RELEASE

published on 05/10/2024 at 22:30, 6 months 10 days ago

Integrated BioPharma Reports Results for its Quarter Ended March 31, 2024
Integrated BioPharma, Inc. reports financial results for Q1 2024, showing stable revenue and net income compared to Q1 2023. The company aims to reduce reliance on key customers. Details and future outlook provided

Financial Results Revenue Net Income Integrated BioPharma Inc. Customer Base
PRESS RELEASE

published on 02/12/2024 at 22:25, 9 months 8 days ago

Integrated BioPharma Reports Results for its Quarter Ended December 31, 2023
Integrated BioPharma, Inc. reports financial results for the quarters and six-month periods ended December 31, 2023 and 2022, with revenue, operating losses, and net loss figures outlined

Financial Results Revenue Integrated BioPharma Inc. Operating Losses Net Loss

Accesswire

Published on 11/21/2024 at 09:00, 33 minutes ago

ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 8 hours 58 minutes ago

Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 9 hours 8 minutes ago

Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies
Published on 11/21/2024 at 00:00, 9 hours 33 minutes ago

Swiss Mining Institute Conference Presentation
Published on 11/20/2024 at 23:00, 10 hours 33 minutes ago

Rektron Group Inc. Announces Appointment of a New Director and Provides Corporate Updates

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 09:01, 32 minutes ago

Original-Research: Netfonds AG (von NuWays AG): Buy
Published on 11/21/2024 at 08:59, 33 minutes ago

Black Friday Savings: Kling AI Offers 50% Off and Free Feature Upgrades
Published on 11/21/2024 at 08:59, 33 minutes ago

Économies Black Friday : Kling AI propose 50 % de réduction et des mises à niveau gratuites des fonctionnalités
Published on 11/21/2024 at 08:15, 1 hour 18 minutes ago

EBIT increases to EUR 55.6 million. Equity (net asset value) increases by EUR 49.3 million to EUR 300.3 million, which corresponds to 70.14 euros per share. The equity ratio rises to 94.85%.
Published on 11/21/2024 at 08:09, 1 hour 23 minutes ago

KAP HOLDS ITS GROUND IN A DIFFICULT INDUSTRY ENVIRONMENT IN THE FIRST NINE MONTHS OF 2024

Les Echos

Published on 11/21/2024 at 06:58, 2 hours 35 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 2 hours 35 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 2 hours 35 minutes ago

Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 13 hours 26 minutes ago

Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 14 hours 13 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting

View all LES ECHOS COMFI WIRE